Generex Biotechnology Corp. Stock Price - GNBT

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Ultimate Trader
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Generex Biotechnology Corp. (QB) GNBT OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.615 0.65 0.61 0.63 0.615 11:46:24
Bid Price Ask Price Spread Spread % News
0.615 0.63 0.015 2.38% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
43 46,486 $ 0.61618 $ 28,644 185,520 0.59 - 3.28
Last Trade Time Type Quantity Stock Price Currency
11:46:24 300 $ 0.615 USD

Generex Biotechnology Corp. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 28.09M 45.31M $ 36.33M - - 1.05M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
528.05k $ - 0.00% - -

more financials information »

Generex Biotechnology Corp. News

Loading Messages....

Latest GNBT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GNBT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.62010.7550.600.6304196455,173-0.0051-0.82%
1 Month0.9751.2140.590.7741441369,250-0.36-36.92%
3 Months2.742.740.591.10195,010-2.13-77.55%
6 Months1.643.280.591.64151,149-1.03-62.5%
1 Year0.753.280.591.72145,882-0.135-18.0%
3 Years6.0025.300.592.0062,692-5.39-89.75%
5 Years6.0025.300.592.0062,692-5.39-89.75%

Generex Biotechnology Corp. Description

Generex Biotechnology is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. Generex is building a new kind of healthcare company that extends beyond traditional models providing support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. In addition to advancing a legacy portfolio of immune-oncology assets, medical devices, and diagnostics, the Company is focused on an acquisition strategy of strategic businesses that complement existing assets and provide immediate sources of revenue and working capital. Recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products. Our newly formed, wholly-owned subsidiary, NuGenerex Distribution Solutions (NDS), integrates our MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.


Your Recent History
USOTC
GNBT
Generex Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.